An innovative method to strengthen evidence for potential drug safety signals using Electronic Health Records
Open Access
- 16 May 2024
- journal article
- research article
- Published by Springer Nature in Journal of Medical Systems
- Vol. 48 (1) , 1-8
Abstract
Reports from spontaneous reporting systems (SRS) are hypothesis generating. Additional evidence such as more reports is required to determine whether the generated drug-event associations are in fact safety signals. However, underreporting of adverse drug reactions (ADRs) delays signal detection. Through the use of natural language processing, different sources of real-world data can be used to proactively collect additional evidence for potential safety signals. This study aims to explore the feasibility of using Electronic Health Records (EHRs) to identify additional cases based on initial indications from spontaneous ADR reports, with the goal of strengthening the evidence base for potential safety signals. For two confirmed and two potential signals generated by the SRS of the Netherlands Pharmacovigilance Centre Lareb, targeted searches in the EHR of the Leiden University Medical Centre were performed using a text-mining based tool, CTcue. The search for additional cases was done by constructing and running queries in the structured and free-text fields of the EHRs. We identified at least five additional cases for the confirmed signals and one additional case for each potential safety signal. The majority of the identified cases for the confirmed signals were documented in the EHRs before signal detection by the Dutch Medicines Evaluation Board. The identified cases for the potential signals were reported to Lareb as further evidence for signal detection. Our findings highlight the feasibility of performing targeted searches in the EHR based on an underlying hypothesis to provide further evidence for signal generation.Keywords
This publication has 41 references indexed in Scilit:
- Signals from the Dutch national spontaneous reporting system: Characteristics and regulatory actionsPharmacoepidemiology and Drug Safety, 2021
- An Electronic Health Record Text Mining Tool to Collect Real‐World Drug Treatment Outcomes: A Validation Study in Patients With Metastatic Renal Cell CarcinomaClinical Pharmacology & Therapeutics, 2020
- Nintedanib and ischemic colitis: Signal assessment with the integrated use of two types of real‐world evidence, spontaneous reports of suspected adverse drug reactions, and observational data from large health‐care databasesPharmacoepidemiology and Drug Safety, 2020
- Mortality among patients due to adverse drug reactions that occur following hospitalisation: a meta-analysisEuropean Journal of Clinical Pharmacology, 2019
- Hospital admissions due to adverse drug reactions in the elderly. A meta-analysisEuropean Journal of Clinical Pharmacology, 2017
- Response to the validity and reliability of a signal impact assessment tool: statistical issue to avoid misinterpretationPharmacoepidemiology and Drug Safety, 2016
- The validity and reliability of a signal impact assessment toolPharmacoepidemiology and Drug Safety, 2016
- Evaluating performance of electronic healthcare records and spontaneous reporting data in drug safety signal detectionInternational Journal of Clinical Pharmacy, 2014
- Evaluation of FDA safety‐related drug label changes in 2010Pharmacoepidemiology and Drug Safety, 2013
- A Reference Standard for Evaluation of Methods for Drug Safety Signal Detection Using Electronic Healthcare Record DatabasesDrug Safety, 2012